56 related articles for article (PubMed ID: 20477378)
1. Identification of a beta-amyloid-binding plasma protein, LRP1: implications for biomarker research and therapy in Alzheimer's disease.
Zetterberg H
Biomark Med; 2007 Oct; 1(3):347-8. PubMed ID: 20477378
[TBL] [Abstract][Full Text] [Related]
2. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
Deane R; Bell RD; Sagare A; Zlokovic BV
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.
Sagare AP; Deane R; Zlokovic BV
Pharmacol Ther; 2012 Oct; 136(1):94-105. PubMed ID: 22820095
[TBL] [Abstract][Full Text] [Related]
4. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Peripheral Transport Proteins and Plasma Amyloid-β in Patients with Alzheimer's Disease Were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
Gao L; Wang J; Jiang Y; Wei S; Shang S; Chen C; Dang L; Huo K; Deng M; Wang J; Qu Q
J Alzheimers Dis; 2020; 78(2):699-709. PubMed ID: 33016902
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of Abeta metabolism-associated molecules from D-galactose/AlCl(3) induced mouse brain.
Luo Y; Niu F; Sun Z; Cao W; Zhang X; Guan D; Lv Z; Zhang B; Xu Y
Mech Ageing Dev; 2009 Apr; 130(4):248-52. PubMed ID: 19150622
[TBL] [Abstract][Full Text] [Related]
7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
8. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
[TBL] [Abstract][Full Text] [Related]
9. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
[TBL] [Abstract][Full Text] [Related]
10. Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse.
Seubert P; Barbour R; Khan K; Motter R; Tang P; Kholodenko D; Kling K; Schenk D; Johnson-Wood K; Schroeter S; Gill D; Jacobsen JS; Pangalos M; Basi G; Games D
Neurodegener Dis; 2008; 5(2):65-71. PubMed ID: 18182780
[TBL] [Abstract][Full Text] [Related]
11. The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study.
Gao L; Jiang Y; Wei S; Shang S; Li P; Chen C; Dang L; Wang J; Huo K; Deng M; Wang J; Zhang R; Qu Q
J Alzheimers Dis; 2018; 65(3):951-961. PubMed ID: 30103331
[TBL] [Abstract][Full Text] [Related]
12. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
Bates KA; Verdile G; Li QX; Ames D; Hudson P; Masters CL; Martins RN
Mol Psychiatry; 2009 May; 14(5):469-86. PubMed ID: 18794889
[TBL] [Abstract][Full Text] [Related]
13. Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion.
Liu H; Xing A; Wang X; Liu G; Li L
Neurobiol Aging; 2012 Apr; 33(4):826.e31-42. PubMed ID: 21813211
[TBL] [Abstract][Full Text] [Related]
14. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
15. LRP1 shedding in human brain: roles of ADAM10 and ADAM17.
Liu Q; Zhang J; Tran H; Verbeek MM; Reiss K; Estus S; Bu G
Mol Neurodegener; 2009 Apr; 4():17. PubMed ID: 19371428
[TBL] [Abstract][Full Text] [Related]
16. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
[TBL] [Abstract][Full Text] [Related]
17. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
Dodart JC; Bales KR; Gannon KS; Greene SJ; DeMattos RB; Mathis C; DeLong CA; Wu S; Wu X; Holtzman DM; Paul SM
Nat Neurosci; 2002 May; 5(5):452-7. PubMed ID: 11941374
[TBL] [Abstract][Full Text] [Related]
18. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
Fagan AM; Mintun MA; Mach RH; Lee SY; Dence CS; Shah AR; LaRossa GN; Spinner ML; Klunk WE; Mathis CA; DeKosky ST; Morris JC; Holtzman DM
Ann Neurol; 2006 Mar; 59(3):512-9. PubMed ID: 16372280
[TBL] [Abstract][Full Text] [Related]
19. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
[TBL] [Abstract][Full Text] [Related]
20. The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease.
Kanekiyo T; Bu G
Front Aging Neurosci; 2014; 6():93. PubMed ID: 24904407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
